Do We Need Meropenem Treatment Beyond 7 Days in Febrile Neutropenic Patients: A Cost-Effectiveness Analysis by Leyla Yumrukaya, Arnold Hagens, Ahmet Çağkan İnkaya, Gökhan Metan, Maarten Postma, Selen Yeğenoğlu, Murat Akova

Get full text

Comparison of the effect of carbapenem and piperacillin-tazobactam on the development of fecal colonization with carbapenem resistant Enterobacterales by Tuğba Pamukçu, Gökhan Metan, Gökçen Telli, Gülçin Telli Dizman, Gülşen Hazırolan, Pınar Zarakolu, Murat Akova

Get full text

Emulating a Target Trial of Early Compared to Late Initiation of Appropriate Antibiotic Therapy for Hospital-acquired Monobacterial Gram-negative Blood Stream Infections by Abdullah Tarik Aslan, Yukiko Ezure, Elif Seren Tanriverdi, Osman Dag, Cansu Cimen, Baris Otlu, Patrick Harris, Murat Akova, David L. Paterson

Get full text

Loss of OmpK35 and Glycine-aspartic acid Duplication in ompK36 Negatively Affect the in vitro Synergy of Meropenem in Combination with Piperacillin/tazobactam or Imipenem Against O... by Abdullah Tarik Aslan, Mervenur Demir, Elif Seren Tanriverdi, Budi Permana, Rhys Izuagbe, Kay A. Ramsay, Brian Forde, Baris Otlu, David L. Paterson, Patrick Harris, Murat Akova, Gulsen Hazirolan

Get full text